Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Prostate Cancer

Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Cancer Care Centers of South Texas
mi
from
San Antonio, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Cancer Care Centers of South Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Oncology Cancer Center - Sugar Land
mi
from
Sugar Land, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Oncology Cancer Center - Sugar Land
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Deke Slayton Cancer Center
mi
from
Webster, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Deke Slayton Cancer Center
mi
from
Webster, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Oncology & Hematology Associates Of Southwest Virginia, Inc.
mi
from
Salem, VA
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Oncology & Hematology Associates Of Southwest Virginia, Inc.
mi
from
Salem, VA
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Highline Medical Oncology
mi
from
Burien, WA
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Highline Medical Oncology
mi
from
Burien, WA
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Pudget Sound Cancer Center
mi
from
Edmonds, WA
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Pudget Sound Cancer Center
mi
from
Edmonds, WA
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Cancer Care Northwest
mi
from
Spokane, WA
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Cancer Care Northwest
mi
from
Spokane, WA
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Northwest Cancer Specialists
mi
from
Vancouver, WA
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Northwest Cancer Specialists
mi
from
Vancouver, WA
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Florida Cancer Institute- New Hope
mi
from
New Port Richey, FL
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Florida Cancer Institute- New Hope
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Hematology-Oncology Associates of Illinois
mi
from
Chicago, IL
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Hematology-Oncology Associates of Illinois
mi
from
Chicago, IL
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Central Indiana Cancer Centers
mi
from
Indianapolis, IN
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Central Indiana Cancer Centers
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Alliance Hematology Oncology PA.
mi
from
Westminster, MD
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Alliance Hematology Oncology PA.
mi
from
Westminster, MD
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Minnesota Oncology and Hematology, PA
mi
from
Minneapolis, MN
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Minnesota Oncology and Hematology, PA
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
New York Oncology Hematology PC
mi
from
Albany, NY
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
New York Oncology Hematology PC
mi
from
Albany, NY
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Willamette Valley Cancer Center
mi
from
Springfield, OR
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Willamette Valley Cancer Center
mi
from
Springfield, OR
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Medical Oncology Associates of Wyoming Valley, PC
mi
from
Kingston, PA
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Medical Oncology Associates of Wyoming Valley, PC
mi
from
Kingston, PA
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Cancer Centers of the Carolinas
mi
from
Greenville, SC
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Cancer Centers of the Carolinas
mi
from
Greenville, SC
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Cancer Center, Abilene
mi
from
Abilene, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Cancer Center, Abilene
mi
from
Abilene, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Oncology, P.A. -Amarillo
mi
from
Amarillo, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Oncology, P.A. -Amarillo
mi
from
Amarillo, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Cancer Center
mi
from
Arlington, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Cancer Center
mi
from
Arlington, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Oncology - Round Rock Cancer Center
mi
from
Austin, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Oncology - Round Rock Cancer Center
mi
from
Austin, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Mamie Mcfaddin Ward Cancer Center Texas Oncology
mi
from
Beaumont, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Mamie Mcfaddin Ward Cancer Center Texas Oncology
mi
from
Beaumont, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Oncology, PA
mi
from
Dallas, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Oncology, PA
mi
from
Dallas, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Oncology/Methodist Charlton Cancer Ctr.
mi
from
Dallas, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Oncology/Methodist Charlton Cancer Ctr.
mi
from
Dallas, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Oncology P.A.
mi
from
Fort Worth, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Oncology P.A.
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Oncology PA
mi
from
Garland, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Oncology PA
mi
from
Garland, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Longview Cancer Center
mi
from
Longview, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Longview Cancer Center
mi
from
Longview, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Oncology - Allison Cancer Center
mi
from
Midland, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Oncology - Allison Cancer Center
mi
from
Midland, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Cancer Care Centers of South Texas-HOAST
mi
from
San Antonio, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Cancer Care Centers of South Texas-HOAST
mi
from
San Antonio, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Cancer Center - Sherman
mi
from
Sherman, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Cancer Center - Sherman
mi
from
Sherman, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Tyler Cancer Center
mi
from
Tyler, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Tyler Cancer Center
mi
from
Tyler, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Oncology Cancer Care And Research Center
mi
from
Waco, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Oncology Cancer Care And Research Center
mi
from
Waco, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Virginia Oncology Associates
mi
from
Norfolk, VA
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Virginia Oncology Associates
mi
from
Norfolk, VA
Click here to add this to my saved trials
High-Dose Stereotactic Radiation for Prostate Cancer
High-Dose Stereotactic Body Radiation Therapy in Treating Patients With Low-, Intermediate-, or High-Risk Localized Prostate Cancer
Status: Enrolling
Updated:  2/4/2016
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
High-Dose Stereotactic Radiation for Prostate Cancer
High-Dose Stereotactic Body Radiation Therapy in Treating Patients With Low-, Intermediate-, or High-Risk Localized Prostate Cancer
Status: Enrolling
Updated: 2/4/2016
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
Urology Associates Medical Group
mi
from
Burbank, CA
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
Urology Associates Medical Group
mi
from
Burbank, CA
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
Tower Urology
mi
from
Los Angeles, CA
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
Tower Urology
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
VA Greater Los Angeles
mi
from
Los Angeles, CA
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
VA Greater Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
San Bernardino Urological Assoc.
mi
from
San Bernardino, CA
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
San Bernardino Urological Assoc.
mi
from
San Bernardino, CA
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
Genesis Healthcare Partners
mi
from
San Diego, CA
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
Genesis Healthcare Partners
mi
from
San Diego, CA
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
Urology Specialists of So. California
mi
from
Torrance, CA
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
Urology Specialists of So. California
mi
from
Torrance, CA
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
Connecticut Clinical Research Center, LLC
mi
from
Middlebury, CT
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
Connecticut Clinical Research Center, LLC
mi
from
Middlebury, CT
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
So. Florida Medical Research
mi
from
Aventura, FL
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
So. Florida Medical Research
mi
from
Aventura, FL
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
AMPM Research
mi
from
Miami, FL
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
AMPM Research
mi
from
Miami, FL
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
Coastal Medical Center
mi
from
Sarasota, FL
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
Coastal Medical Center
mi
from
Sarasota, FL
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
GTx Investigative Site
mi
from
St Petersburg, FL
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
GTx Investigative Site
mi
from
St Petersburg, FL
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
Pinellas Urology Inc.
mi
from
St. Petersburg, FL
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
Pinellas Urology Inc.
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
Urology of Indiana
mi
from
Greenwood, IN
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
Urology of Indiana
mi
from
Greenwood, IN
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
First Urology PSC
mi
from
Jeffersonville, IN
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
First Urology PSC
mi
from
Jeffersonville, IN
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
Chesapeake Urology Research Assoc.
mi
from
Towson, MD
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
Chesapeake Urology Research Assoc.
mi
from
Towson, MD
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
Five Valleys Urology
mi
from
Missoula, MT
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
Five Valleys Urology
mi
from
Missoula, MT
Click here to add this to my saved trials